GENTILI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 96
EU - Europa 91
AS - Asia 34
SA - Sud America 8
AF - Africa 7
Totale 236
Nazione #
US - Stati Uniti d'America 96
IT - Italia 35
CN - Cina 11
UA - Ucraina 10
RU - Federazione Russa 9
TR - Turchia 9
IE - Irlanda 8
DE - Germania 7
SE - Svezia 6
SG - Singapore 6
BR - Brasile 5
HK - Hong Kong 5
DK - Danimarca 4
FI - Finlandia 4
GB - Regno Unito 4
CI - Costa d'Avorio 3
MA - Marocco 3
FR - Francia 2
KR - Corea 2
NL - Olanda 2
PE - Perù 2
EC - Ecuador 1
IN - India 1
ZA - Sudafrica 1
Totale 236
Città #
Jacksonville 10
Boardman 8
Chandler 8
Dublin 8
New York 7
Wilmington 7
Seattle 6
Hong Kong 5
Ashburn 4
Bari 4
Fairfield 4
Guangzhou 4
Houston 4
Moscow 4
Abidjan 3
Ann Arbor 3
London 3
Rome 3
Singapore 3
Woodbridge 3
Ancona 2
Beijing 2
Brescia 2
Cambridge 2
Helsinki 2
Lawrence 2
Lima 2
Nuremberg 2
Princeton 2
San Benedetto del Tronto 2
San Mateo 2
Turin 2
Venice 2
Amsterdam 1
Araçatuba 1
Caraguatatuba 1
Civitanova Marche 1
Des Moines 1
Durban 1
Easley 1
Fermo 1
Gragnano 1
Guayaquil 1
Jiaxing 1
Kilburn 1
Lagoa Santa 1
Munich 1
Porto 1
Pune 1
San Diego 1
Santo Antônio 1
Volta Redonda 1
Washington 1
Yiwu 1
Totale 148
Nome #
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 94
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 81
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 49
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 24
Totale 248
Categoria #
all - tutte 1.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 2 3
2020/202136 3 3 3 0 14 2 2 2 2 2 2 1
2021/202214 1 2 0 0 0 2 0 2 0 4 0 3
2022/202334 2 4 4 1 2 1 0 2 10 0 8 0
2023/202445 7 1 4 4 7 7 1 5 0 0 0 9
2024/202566 8 6 3 0 4 3 12 2 24 4 0 0
Totale 248